A retrospective, cohort study of adverse events of canagliflozin in patients with T2DM
Latest Information Update: 23 Jul 2020
At a glance
- Drugs Canagliflozin (Primary) ; Dipeptidyl peptidase 4 inhibitors
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 23 Jul 2020 New trial record
- 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association